Immunotherapy Today

Immunotherapy News From Around The World

< Immunotherapy Today home

Author: btwatson

  • Merck KGaA takes second option from cancer immunotherapy pact with F-Star – – pharmaphorum
    Merck KGaA takes second option from cancer immunotherapy pact with F-Star – – pharmaphorum
  • Immunotherapy with CAR T cells results in exceptional patient recovery – EurekAlert
    Immunotherapy with CAR T cells results in exceptional patient recovery – EurekAlert
  • Immunotherapy with CAR T cells results in exceptional patient recovery – EurekAlert
    Immunotherapy with CAR T cells results in exceptional patient recovery – EurekAlert
  • Anti-Mesothelin LMB-100 Helps Immunotherapy Fight Mesothelioma – Mesothelioma Guide
    Anti-Mesothelin LMB-100 Helps Immunotherapy Fight Mesothelioma – Mesothelioma Guide
  • Study led by Roswell doctor supports the treatment of melanoma with immunotherapy drug Keytruda – WGRZ.com
  • Immunotherapy combination could help patients with cancer fight COVID-19 – Healio
    Immunotherapy combination could help patients with cancer fight COVID-19 – Healio
  • Immunotherapy in Advanced Lung Cancer – Cancer Network
  • Providing immunotherapies with a boost could reduce cancer recurrence – Drug Target Review
    Providing immunotherapies with a boost could reduce cancer recurrence – Drug Target Review
  • Immunotherapy with CAR T cells results in exceptional patient recovery – Medical Xpress
    Immunotherapy with CAR T cells results in exceptional patient recovery – Medical Xpress
  • Gilead and Arcus complete closing of ten-year immunotherapy partnership – PMLiVE
    Gilead and Arcus complete closing of ten-year immunotherapy partnership – PMLiVE
< Newer Entries   |   Older Entries >
Copyright 2018 ImmunoTherapyToday.com